Milan Zdravković

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes

Michael A. Nauck, Anders Frid, Kjeld Hermansen et al. · Diabetes Care · 2008 · 1.1K citations · Full text

The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men

Henrik Agersø, Lene Jensen, B. Elbrønd et al. · Diabetologia · 2002 · 503 citations · Full text

Physiology, Pharmacology, Clinical Pharmacology +5

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of a Single-Dose of NN2211, a Long-Acting Glucagon-Like Peptide 1 Derivative, in Healthy Male Subjects

B. Elbrønd, Grethe Jakobsen, Søren Erik Larsen et al. · Diabetes Care · 2002 · 282 citations · Full text

Effect of renal impairment on the pharmacokinetics of the GLP‐1 analogue liraglutide

Lisbeth V. Jacobsen, Charlotte Hindsberger, Richard A. Robson et al. · British Journal of Clinical Pharmacology · 2009 · 214 citations · Full text

Liraglutide, a once‐daily human GLP‐1 analogue, improves pancreatic B‐cell function and arginine‐stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus

T. Vilsbøll, Birgitte Brock, Hans Perrild et al. · Diabetic Medicine · 2008 · 210 citations